ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer

Kelly K. Hunt; Vera J. Suman; Hannah F. Wingate; A. Marilyn Leitch; Gary Unzeitig; Judy C. Boughey; Funda Meric-Bernstam; Matthew J. Ellis; John A. Olson

doi:10.1245/s10434-023-13149-4

ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer

Kelly K. Hunt, Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey, Funda Meric-Bernstam, Matthew J. Ellis, John A. Olson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2119-2120
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	30
Issue number	4
DOIs	https://doi.org/10.1245/s10434-023-13149-4
State	Published - Apr 1 2023

Access to Document

10.1245/s10434-023-13149-4

Cite this

Hunt, K. K., Suman, V. J., Wingate, H. F., Leitch, A. M., Unzeitig, G., Boughey, J. C., Meric-Bernstam, F., Ellis, M. J., & Olson, J. A. (2023). ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. Annals of Surgical Oncology, 30(4), 2119-2120. https://doi.org/10.1245/s10434-023-13149-4

Hunt, Kelly K. ; Suman, Vera J. ; Wingate, Hannah F. et al. / ASO Visual Abstract : Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. In: Annals of Surgical Oncology. 2023 ; Vol. 30, No. 4. pp. 2119-2120.

@article{bc1b5a09baa14d89bf7b6ce0503a071a,

title = "ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer",

author = "Hunt, {Kelly K.} and Suman, {Vera J.} and Wingate, {Hannah F.} and Leitch, {A. Marilyn} and Gary Unzeitig and Boughey, {Judy C.} and Funda Meric-Bernstam and Ellis, {Matthew J.} and Olson, {John A.}",

year = "2023",

month = apr,

day = "1",

doi = "10.1245/s10434-023-13149-4",

language = "English",

volume = "30",

pages = "2119--2120",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

number = "4",

}

Hunt, KK, Suman, VJ, Wingate, HF, Leitch, AM, Unzeitig, G, Boughey, JC, Meric-Bernstam, F, Ellis, MJ & Olson, JA 2023, 'ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer', Annals of Surgical Oncology, vol. 30, no. 4, pp. 2119-2120. https://doi.org/10.1245/s10434-023-13149-4

ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. / Hunt, Kelly K.; Suman, Vera J.; Wingate, Hannah F. et al.
In: Annals of Surgical Oncology, Vol. 30, No. 4, 01.04.2023, p. 2119-2120.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - ASO Visual Abstract

T2 - Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer

AU - Hunt, Kelly K.

AU - Suman, Vera J.

AU - Wingate, Hannah F.

AU - Leitch, A. Marilyn

AU - Unzeitig, Gary

AU - Boughey, Judy C.

AU - Meric-Bernstam, Funda

AU - Ellis, Matthew J.

AU - Olson, John A.

PY - 2023/4/1

Y1 - 2023/4/1

UR - http://www.scopus.com/inward/record.url?scp=85150752380&partnerID=8YFLogxK

U2 - 10.1245/s10434-023-13149-4

DO - 10.1245/s10434-023-13149-4

M3 - Article

C2 - 36745260

AN - SCOPUS:85150752380

SN - 1068-9265

VL - 30

SP - 2119

EP - 2120

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 4

ER -

Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC et al. ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. Annals of Surgical Oncology. 2023 Apr 1;30(4):2119-2120. doi: 10.1245/s10434-023-13149-4

Access to Document

Other files and links

Cite this